Robbins Umeda LLP Is Investigating Cephalon, Inc. Acquisition for Shareholders

Robbins Umeda LLP, a shareholder rights litigation firm, is interested in helping shareholders of Cephalon, Inc. (NASDAQ: CEPH). The firm has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the board of directors of Cephalon in connection with their efforts to sell Cephalon to Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA).

If you own stock in Cephalon and would like more information about your shareholder rights, please contact Gregory E. Del Gaizo at 800-350-6003 or via the shareholder information form on our website.

On May 2, 2011, Teva and Cephalon announced that their boards of directors have approved a definitive agreement under which Teva will acquire all outstanding shares of Cephalon for $81.50 per share. The transaction is expected to be completed in the third quarter of 2011.

The investigation focuses on whether Cephalon's board is undertaking a fair process to obtain maximum value for its shareholders. The purchase price of $81.50 represents only a 6% premium to Cephalon's closing price on April 29, 2011, the last trading day prior to the acquisition announcement. One analyst raised its price target of $92 following the company's record sales and strong earnings reported on February 20, 2011. Moreover, another analyst stated in their March 30, 2011 report that they "believe that appropriate takeover value is approximately $119 per share."

Robbins Umeda LLP represents individual and institutional shareholders in derivative, direct, and class action lawsuits. The firm's skilled litigation teams include former federal prosecutors, former defense counsel from top multinational corporate law firms, and career shareholder rights attorneys. Robbins Umeda LLP has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to http://www.robbinsumeda.com.

Press release link: http://www.robbinsumeda.com/shareholders-rights-blog/cephalon-inc/

Attorney Advertising. Past results do not guarantee a similar outcome.

Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From Jun 2024 to Jul 2024